Rchr
J-GLOBAL ID:201801005064343556   Update date: Jan. 09, 2024

Umemura Atsushi

ウメムラ アツシ | Umemura Atsushi
Affiliation and department:
Research field  (4): Molecular biology ,  Pharmacology ,  Tumor biology ,  Gastroenterology
Research keywords  (5): 薬理学 ,  Molecular Biology ,  Cancer ,  Gastroenterology ,  Liver disease
Research theme for competitive and other funds  (2):
  • 2019 - 2022 The development of NASH-HCC prevention targeting EGFR
  • 2015 - 2017 The role of p62 in the HCC initiation and progression
Papers (89):
  • Kanji Yamaguchi, Toshihide Shima, Yasuhide Mitsumoto, Yuya Seko, Atsushi Umemura, Yoshito Itoh, Atsushi Nakajima, Shuichi Kaneko, Kenichi Harada, Timothy Watkins, et al. Fibro-Scope V1.0.1: an artificial intelligence/neural network system for staging of nonalcoholic steatohepatitis. Hepatology international. 2023. 17. 3. 573-583
  • Kanji Yamaguchi, Yuya Seko, Takamitsu Sakai, Satomi Kitano, Hiromi Okabe, Seita Kataoka, Michihisa Moriguchi, Atsushi Umemura, Yoshito Itoh. Comparison of portal vein hemodynamics with ultrasound-based elastography for the prediction of liver fibrosis in patients with chronic liver disease. Scientific reports. 2023. 13. 1. 3425-3425
  • Ruolei Wang, Lirong Liang, Misaki Matsumoto, Kazumi Iwata, Atsushi Umemura, Feng He. Reactive Oxygen Species and NRF2 Signaling, Friends or Foes in Cancer?. Biomolecules. 2023. 13. 2
  • Atsushi Umemura. Editorial: Impacts of drug-induced oxidative stress. Frontiers in medicine. 2023. 10. 1191864-1191864
  • Takeshi Okanoue, Kanji Yamaguchi, Toshihide Shima, Yasuhide Mitsumoto, Masayuki Mizuno, Takayuki Katayama, Yuya Seko, Michihisa Moriguchi, Atsushi Umemura, Yoshito Itoh, et al. The serum levels of IgM-free apoptosis inhibitor of macrophage /CD5L as a predictive and early diagnostic marker for NASH-associated hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology. 2022. 52. 12. 998-1008
more...
MISC (146):
  • 片岡 星太, 楳村 敦詩, 瀬古 裕也, 山口 寛二, 森口 理久, 伊藤 義人. 膵臓における変化がNASH発癌に与える影響. 肝臓. 2023. 64. Suppl.1. A399-A399
  • 楳村敦詩. Drug-induced Liver Injury (DILI) with Jaundice. 臨床消化器内科. 2023. 38. 3. 271-277
  • 高橋 彩, 楳村 敦詩, 伊藤 義人. 肝がん研究-ホストゲノム・免疫・病理 分子標的薬は肝癌細胞のIFNγ/STAT1シグナル活性化を介してHLA-1発現を増強する. 肝臓. 2022. 63. Suppl.1. A119-A119
  • 楳村敦詩. Fatty Liver Disease and Liver Cancer. 京都府立医科大学雑誌. 2022. 131. 3. 209-218
  • 片岡 星太, 楳村 敦詩, 伊藤 義人. 肝疾患における臓器連関の役割 膵Kras変異が非アルコール性脂肪肝炎に与える影響. 肝臓. 2021. 62. Suppl.3. A658-A658
more...
Education (2):
  • 2003 - Kyoto Prefectural University of Medicine Graduate School of Medical Science Molecular Gastroentelorogy and Hepatology
  • - 2000 Kyoto Prefectural University of Medicine
Professional career (1):
  • 医学博士 (京都府立医科大学大学院)
Work history (1):
  • 2001/04 - 2003/03 済生会京都府病院 内科 医員
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page